ProShares Ultra Nasdaq Biotechnology (BIB) Holdings $47.58 +1.27 (+2.74%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$47.54 -0.03 (-0.07%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 50 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A27.60%3,2762NASDAQ BIO INDEX SWAP BNP PARIBASN/A26.00%3,0863NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A25.68%3,0484NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALN/A20.39%2,4205NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A17.33%2,0576NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A9.49%1,1267VRTXVertex Pharmaceuticals$501.15+0.5%6.73%6,6778GILDGilead Sciences$103.68+0.4%6.10%28,0259AMGNAmgen$281.22-0.9%5.92%10,39910REGNRegeneron Pharmaceuticals$605.61+2.6%5.17%4,295 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11AZNAstraZeneca$72.44+2.7%3.26%23,26312ALNYAlnylam Pharmaceuticals$259.39+1.7%2.56%5,17213SMMTSummit Therapeutics$27.90+13.1%2.00%29,47014ARGXargenx$649.67+1.5%1.56%1,27815BIIBBiogen$123.53+2.2%1.41%5,84716SNYSanofi$55.44+2.5%1.25%11,47917RPRXRoyalty Pharma$32.89+1.3%1.12%17,31218UTHRUnited Therapeutics$294.60+0.3%1.08%1,79519INSMInsmed$72.30-0.5%1.05%7,23120ILMNIllumina$77.88+1.8%0.99%6,32821BMRNBioMarin Pharmaceutical$62.03-1.1%0.97%7,62122BNTXBioNTech$104.94+2.5%0.93%3,97523INCYIncyte$62.53+0.8%0.92%7,73124ONCBeigene$255.77+0.1%0.85%1,67225EXELExelixis$39.60+1.8%0.84%11,18126MRNAModerna$27.61+2.1%0.84%15,41327NBIXNeurocrine Biosciences$109.68+2.9%0.84%3,98428ASNDAscendis Pharma A/S$172.06+2.7%0.78%2,41229VTRSViatris$8.65+2.1%0.76%47,68730MEDPMedpace$305.11+0.9%0.72%1,21731TEMTempus AI$57.06+10.0%0.68%6,67932ROIVRoivant Sciences$11.48-0.9%0.63%28,50633HALOHalozyme Therapeutics$61.19+1.9%0.59%4,92034RVMDRevolution Medicines$40.72+0.2%0.57%7,42735MDGLMadrigal Pharmaceuticals$315.48-3.7%0.56%88236BBIOBridgeBio Pharma$38.57+0.4%0.55%7,59837JAZZJazz Pharmaceuticals$120.05+2.4%0.52%2,42638SRPTSarepta Therapeutics$63.51+1.2%0.47%3,87739GHGuardant Health$46.85-4.1%0.46%4,93140BPMCBlueprint Medicines$104.64+5.4%0.45%2,553Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now.41ADMAADMA Biologics$23.52+1.1%0.42%9,44342AXSMAxsome Therapeutics$112.210.0%0.42%1,94843VRNAVerona Pharma$72.73+0.7%0.41%3,14844KRYSKrystal Biotech$166.16+0.3%0.39%1,15145NUVLNuvalent$77.46+1.6%0.39%2,64346IONSIonis Pharmaceuticals$32.78+3.4%0.38%6,35147CYTKCytokinetics$37.35-13.0%0.37%4,73048ALKSAlkermes$31.78+3.9%0.36%6,49649PCVXVaxcyte$35.39+0.4%0.35%5,14450PTCTPTC Therapeutics$49.95+0.9%0.32%3,151 Geographic ExposureUnited States98.3%Ireland1.0%Bermuda0.6%Canada0.4%Netherlands0.4%Switzerland0.3%United Kingdom0.2%Luxembourg0.2%Jersey0.2%Singapore0.1%Currency ExposureUSD107.3%Sector ExposureHealth Care70.8%Consumer Discretionary0.7%Energy0.1%Biotechnology0.1%Industry ExposureBiotechnology64.4%Pharmaceuticals3.3%Health Care Equipment & Supplies1.6%Diversified Consumer Services1.2%Life Sciences Tools & Services1.0%Distributors0.2%Renewable Energy0.1%SubIndustry ExposureBiotechnology61.8%Pharmaceuticals4.0%Life Sciences Tools & Services3.0%Health Care Equipment0.2%Renewable Energy Equipment0.1%Health Care Supplies0.1% Related Companies and Tools Related Companies F/m Emerald Life Sciences Innovation ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings Global X HealthTech ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings VanEck Biotech ETF Top Holdings This page (NASDAQ:BIB) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
